Biogen pays $900M to resolve whistleblower's MS kickback suit as competition drags on sales - FiercePharma
Just as Biogen’s multiple sclerosis franchise is under serious threat from generics and new competition, the company has decided to pay top dollar to settle a long-running kickback lawsuit center...
Read more